111, Inc.
YI Nasdaq· Retail-Drug Stores And Proprietary Stores
Last close · Oct 27, 2026
$3.00
KIRA · Stoqly’s AI analyst, in plain words
- 111, Inc. had $1.7B of revenue in fiscal 2025, down 12.7% on the year before. Over five years, revenue changed +8.0% a year on average.
- Its operating margin was −0.0%, down 0.0 pts: of every 100 in sales, about −0 is left after running the business.
- 111, Inc. lost $3.1M in fiscal 2025.
- Free cash flow was $16.0M in fiscal 2025, 0.9% of revenue.
- 111, Inc. has $53.3M more cash than debt.
Market cap
$26.1M
P/E
—
Revenue
$1.7B
Net income
−$3.1M
Free cash flow
$16.0M
Operating margin
−0.0%
111, Inc. in 30 seconds · fiscal 2025
Are sales growing?
−12.7%
No. Sales fell 12.7% last year.
Does it make a profit?
−0.2%
No. It lost money last year.
Does profit turn into cash?
0.9%
Partly. 0.9% of sales ends up as free cash.
Is debt under control?
Net cash
Yes. It has more cash than debt.
How healthy are the accounts?
4 / 9
Mixed. It passes 4 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What 111, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F · Apr 30, 2026
- Legal name
- 111, Inc.
- CIK
- 0001738906
111, Inc. · YI
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $1.9B | $2.0B | $2.1B | $2.0B | $1.7B |
| Revenue growth | 62.1% | 4.2% | 5.1% | −5.2% | −12.7% |
| Gross margin | 5.0% | 6.2% | 5.7% | 5.8% | 5.8% |
| Operating margin | −5.2% | −2.7% | −2.3% | 0.0% | −0.0% |
| Net income | −$96.3M | −$55.9M | −$49.9M | −$2.9M | −$3.1M |
| Net margin | −5.0% | −2.8% | −2.4% | −0.1% | −0.2% |
| Diluted EPS | −$12.53 | −$7.43 | −$6.58 | −$1.06 | −$1.06 |
| Cash | |||||
| Cash from operations | −$107M | −$3.4M | −$63.1M | $36.5M | $16.6M |
| Capital expenditure | $9.7M | $4.7M | $1.4M | $2.1M | $0.6M |
| Free cash flow | −$117M | −$8.1M | −$64.5M | $34.4M | $16.0M |
| FCF margin | −6.0% | −0.4% | −3.1% | 1.7% | 0.9% |
| Share buybacks | $0.9M | — | — | — | — |
| Share count change | 0.7% | 0.5% | 1.2% | 1.9% | 1.3% |
| Debt and strength | |||||
| Cash and short-term investments | $133M | $127M | $92.0M | $63.3M | $80.1M |
| Debt incl. finance leases | $40.9M | $25.9M | $47.6M | $22.1M | $26.8M |
| Shareholders' equity | −$27.3M | −$60.1M | −$82.1M | −$88.0M | −$100M |
| Net debt / EBITDA | — | — | — | −15.6x | −40.5x |
| Current ratio | 1.3x | 1.2x | 1.1x | 1.1x | 1.1x |
| Interest coverage | −117.0x | −27.6x | −17.4x | 0.1x | −0.1x |
| Returns and quality | |||||
| Return on equity | −703.3% | — | — | — | — |
| Piotroski F-score | 2 | 5 | 1 | 7 | 4 |
| Altman Z'' | −3.1 | −3.1 | −4.6 | −4.1 | −5.7 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.4M
3 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
111, Inc. · YI
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $3.00 a share, the company is worth $26.1M.
Source: SEC EDGAR XBRL filings (CIK 0001738906). Data updated October 24, 2026. Filed in CNY under US GAAP and converted to US$: income and cash-flow lines at each period's average exchange rate, balance-sheet lines at the period-end rate. For information only — not investment advice. Check the original filings before relying on any figure.